Archives: Articles

The numbers are in: More outdoor seating has helped Center City rebound and appears key to a sustained recovery of Philadelphia’s vibrant downtown.

Some South Asian voters are growing more engaged because U.S. Sen. Kamala Harris is the VP nominee. But the population is politically diverse.

The artists of “To the Polls” use hot-button words and images to make their case for the importance of voting.

The legal action comes as local lawmakers struggle to combat rising violence, with homicides hitting a decade-long high.

Pa. won’t require masks at the polls like it does in other public places, but counties and voters can take steps to ensure safe in-person voting during the pandemic.

IAFF Local 22 members again protest the union's endorsement of Trump, balking at union boss’ decision to cancel meeting.

In a 20-minute speech in Gettysburg Tuesday, Democratic presidential candidate Joe Biden framed the ongoing election as a “battle for the soul of the nation.”

The FDA said vaccine makers should follow trial participants for at least two months to rule out any major side effects before seeking emergency approval.

The statement put them at odds with President Donald Trump’s efforts to discredit the vote.

Hospitalizations have tripled since mid-August in Delaware and the average number of daily cases has doubled.

The administration decided the fate of thousands of businesses across Pennsylvania with little transparency and no explanations for its shifting positions.

The administration is also investigating whether the fundraiser violated state safety guidelines and will make necessary referrals to the Attorney General’s office.

After a dramatic helicopter return from the hospital where he was receiving an unprecedented level of care for COVID-19, Trump's attitude alarmed infectious disease experts.

The U.S. Supreme Court heard arguments this week challenging Delaware’s law that requires a balance of Republicans and Democrats on the state’s top three courts.

The FDA said vaccine makers should follow trial participants for at least two months to rule out safety issues before seeking emergency approval.